What is the diagnosis and recommended management for a 36-year-old woman presenting with an irregular pulse, recent febrile episodes, a history of sore throat, elevated antistreptolysin‑O titre, and moderate mitral regurgitation on echocardiogram with normal left‑ventricular size and systolic function?

Diagnosis: Acute Rheumatic Fever with Carditis (Moderate Mitral Regurgitation)

This 36-year-old woman has acute rheumatic fever (ARF) with carditis, evidenced by her preceding pharyngitis, elevated ASO titer (690 IU/mL), irregular rhythm, febrile episodes, and moderate mitral regurgitation on echocardiography. 1

Diagnostic Reasoning

Evidence of Preceding Group A Streptococcal Infection

• The elevated ASO titer of 690 IU/mL confirms recent group A streptococcal pharyngeal infection 2, 1
• Her history of odynophagia (painful swallowing) 1 month prior represents the antecedent streptococcal pharyngitis that triggers the autoimmune cascade 2, 3

Major Jones Criteria Met

• Carditis is present, documented by moderate mitral regurgitation on 2D-echo with preserved LV function (EF 55%) 1, 4
• The irregular rhythm likely represents atrial arrhythmia secondary to acute valvulitis and left atrial involvement 5

Minor Jones Criteria Met

• Fever documented 1 week prior to admission 1
• The clinical presentation satisfies the American Heart Association diagnostic framework: evidence of GAS infection plus major criteria (carditis) with supporting minor criteria (fever) 1

Thyroid Function

• Normal TSH (1.430), FT3 (3.33), and FT4 (1.03) appropriately exclude thyroid-mediated causes of irregular rhythm and help confirm the cardiac manifestations are rheumatic in origin 1

Disease Staging and Prognosis

This patient has Stage C (Advanced RHD) based on World Heart Federation 2023 criteria because moderate mitral regurgitation automatically qualifies as advanced disease regardless of morphological features. 4

• The presence of moderate MR indicates high risk for clinical complications and potential progression 4
• Approximately 30% of mild RHD may regress, but moderate disease carries substantially higher risk of progression despite optimal prophylaxis 4
• The posterior wall hypertrophy noted on echo may reflect early compensatory remodeling in response to volume overload from MR 4

Management Protocol

Immediate Treatment (Acute Phase)

1. Eradicate Streptococcal Infection

• Administer benzathine penicillin G 1.2 million units IM as a single dose (preferred) 2, 1
• Alternative if penicillin-allergic: Azithromycin 500 mg daily for 5 days 3
• This must be initiated even though the acute pharyngitis has resolved, as residual organisms may persist 2

2. Anti-inflammatory Therapy for Carditis

• Prednisone 1–2 mg/kg/day (maximum 60–80 mg/day) for 2–3 weeks, then taper over 2–3 weeks is indicated for moderate carditis with heart failure risk 1
• Naproxen 500 mg twice daily can be added for symptomatic relief but corticosteroids are preferred when carditis is present 1, 3
• Monitor for heart failure development (currently no rales or pulmonary congestion, but moderate MR warrants vigilance) 1

3. Manage Irregular Rhythm

• Obtain 12-lead ECG to characterize the arrhythmia (likely atrial fibrillation or frequent atrial ectopy) 1
• Rate control with beta-blockers (metoprolol 25–50 mg twice daily) if atrial fibrillation confirmed 5
• Anticoagulation decision based on CHA₂DS₂-VASc score if sustained atrial fibrillation documented 5

Long-Term Secondary Prophylaxis (Critical)

Benzathine penicillin G 1.2 million units IM every 3–4 weeks for a minimum of 10 years or until age 46 (whichever is longer), given her moderate carditis. 2, 4

• This is non-negotiable and represents the single most important intervention to prevent recurrent ARF and progressive valve damage 2, 4
• The World Heart Federation emphasizes that every 3-week dosing is superior to 4-week intervals in high-risk patients 4
• If penicillin-allergic: Azithromycin 250 mg daily as continuous prophylaxis 3
• Patients with carditis require prophylaxis until age 40 or 10 years after the last episode, whichever is longer; given her moderate MR at age 36, she requires prophylaxis until at least age 46 2, 4

Echocardiographic Surveillance

Repeat transthoracic echocardiography every 6 months for the first 2 years, then annually thereafter. 4

• Stage C disease (moderate MR) mandates closer surveillance at 6-month intervals initially 4
• Monitor specifically for:
  • Progression of MR severity (EROA, regurgitant volume) 4
  • Development of mitral stenosis from commissural fusion and scarring 2, 4
  • Left atrial enlargement 4
  • Pulmonary hypertension (systolic PA pressure) 4
  • LV systolic dysfunction (EF decline below 60%) 4
  • Emergence of morphological features: anterior leaflet thickening ≥3 mm, chordal thickening, restricted leaflet motion, "hockey-stick" deformity 4

Indications for Surgical Referral (Future Monitoring)

Refer to cardiothoracic surgery if any of the following develop 4:

• Symptoms (NYHA class II–IV dyspnea, fatigue, exercise intolerance)
• LVEF falls below 60%
• Progressive LV dilatation (LVEDV or LVESV increase >15% from baseline)
• Pulmonary hypertension (PA systolic pressure >50 mmHg)
• Development of severe MR

Critical Pitfalls to Avoid

Do not dismiss this as "functional" or degenerative MR in a young patient with recent pharyngitis and elevated ASO titer. 4

• Any structural or functional mitral abnormality following documented streptococcal infection should be presumed rheumatic until proven otherwise 4
• Failure to initiate secondary prophylaxis leads to recurrent ARF in 50–75% of cases within 5 years, with cumulative valve damage 2, 4
• Short courses of antibiotics (<10 days) for the initial pharyngitis fail to prevent ARF in up to 49% of cases, as demonstrated in the Italian cohort where 58.3% of patients who received antibiotics still developed carditis 6
• Subclinical carditis occurs in 27% of ARF cases; echocardiography is mandatory even when murmurs are soft or absent 6, 7
• The normal LV dimensions and preserved EF (55%) do not exclude significant carditis—moderate MR itself defines advanced disease and high complication risk 4

Patient Education and Follow-Up

• Counsel on strict adherence to monthly benzathine penicillin injections—missed doses dramatically increase recurrence risk 2, 4
• Educate about endocarditis prophylaxis for dental and invasive procedures (separate from ARF prophylaxis) 4
• Emphasize prompt evaluation for any future pharyngitis to enable early treatment within 9 days 2
• Arrange cardiology follow-up within 2–4 weeks to review echo findings and adjust management 4
• Provide written documentation of RHD diagnosis for future healthcare encounters 4